Literature DB >> 12065514

Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS).

Joan Y Hou1, James E Graham, Josephine E Clark-Curtiss.   

Abstract

Selective capture of transcribed sequences (SCOTS) has been employed to identify 54 cDNA molecules that represent 46 genes that are expressed by Mycobacterium avium during growth in human macrophages. Some cDNA molecules correspond to genes that are apparently expressed 48 h after infection of macrophages, while others correspond to genes expressed 110 h after infection, and still others correspond to genes expressed throughout the course of infection in our model system. Genes expressed by M. avium during growth in macrophages include genes encoding enzymes of several biosynthetic pathways (pyrimidines, mycobactin, and polyketides); genes that encode enzymes involved in intermediary metabolism, energy metabolism (tricarboxylic acid cycle, glyoxalate shunt), and nitrogen metabolism; and genes that encode regulatory proteins. A number of genes of unknown function were also identified, including genes that code for proteins similar to members of the PPE family of proteins of Mycobacterium tuberculosis and proteins similar to those encoded by the M. tuberculosis mce genes, which have been previously associated with mycobacterial virulence. The SCOTS technique, followed by enrichment for cDNA molecules that are up-regulated or are uniquely expressed by M. avium during growth in human macrophages (compared to growth in laboratory broth culture), allows recovery and identification of a greater diversity of cDNA molecules than does subtractive hybridization between cDNA mixtures from macrophage-grown and broth-grown M. avium. Data are presented demonstrating the reproducibility of recovery of a subset of cDNA molecules from cDNA mixtures purified by SCOTS on several different occasions. These results further demonstrate the beneficial utility of the SCOTS technique for identifying genes whose products are needed for successful survival and growth by an organism in a specific environment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065514      PMCID: PMC128060          DOI: 10.1128/IAI.70.7.3714-3726.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  Clinical aspects of mycobacterial infections in HIV infection.

Authors:  R J Coker; T J Hellyer; I N Brown; J N Weber
Journal:  Res Microbiol       Date:  1992-05       Impact factor: 3.992

2.  Intramacrophage growth of Mycobacterium avium during infection of mice.

Authors:  C Frehel; C de Chastellier; C Offredo; P Berche
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

Authors:  L S Schlesinger; C G Bellinger-Kawahara; N R Payne; M A Horwitz
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

4.  Natural history of disseminated Mycobacterium avium complex infection in AIDS.

Authors:  M A Jacobson; P C Hopewell; D M Yajko; W K Hadley; E Lazarus; P K Mohanty; G W Modin; D W Feigal; P S Cusick; M A Sande
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

5.  Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.

Authors:  L S Schlesinger; M A Horwitz
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

6.  Selection of bacterial virulence genes that are specifically induced in host tissues.

Authors:  M J Mahan; J M Slauch; J J Mekalanos
Journal:  Science       Date:  1993-01-29       Impact factor: 47.728

7.  Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic.

Authors:  A J Crowle; R Dahl; E Ross; M H May
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins.

Authors:  L E Bermudez; L S Young; H Enkel
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

9.  Mycobacterium avium-M. intracellulare binds to the integrin receptor alpha v beta 3 on human monocytes and monocyte-derived macrophages.

Authors:  S P Rao; K Ogata; A Catanzaro
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

Review 10.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more
  31 in total

Review 1.  Unraveling the secret lives of bacteria: use of in vivo expression technology and differential fluorescence induction promoter traps as tools for exploring niche-specific gene expression.

Authors:  Hans Rediers; Paul B Rainey; Jos Vanderleyden; René De Mot
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

2.  The two-component regulatory system mtrAB is required for morphotypic multidrug resistance in Mycobacterium avium.

Authors:  Gerard A Cangelosi; Julie S Do; Robert Freeman; John G Bennett; Makeda Semret; Marcel A Behr
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Global analysis of Helicobacter pylori gene expression in human gastric mucosa.

Authors:  James E Graham; Richard M Peek; Uma Krishna; Timothy L Cover
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Mimicry of the pathogenic mycobacterium vacuole in vitro elicits the bacterial intracellular phenotype, including early-onset macrophage death.

Authors:  Julie Early; Luiz E Bermudez
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

5.  Species of environmental mycobacteria differ in their abilities to grow in human, mouse, and carp macrophages and with regard to the presence of mycobacterial virulence genes, as observed by DNA microarray hybridization.

Authors:  Melanie J Harriff; Martin Wu; Michael L Kent; Luiz E Bermudez
Journal:  Appl Environ Microbiol       Date:  2007-11-02       Impact factor: 4.792

6.  Attenuation of Mycobacterium tuberculosis by disruption of a mas-like gene or a chalcone synthase-like gene, which causes deficiency in dimycocerosyl phthiocerol synthesis.

Authors:  Tatiana D Sirakova; Vinod S Dubey; Michael H Cynamon; Pappachan E Kolattukudy
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production.

Authors:  Alessandro Michelucci; Thekla Cordes; Jenny Ghelfi; Arnaud Pailot; Norbert Reiling; Oliver Goldmann; Tina Binz; André Wegner; Aravind Tallam; Antonio Rausell; Manuel Buttini; Carole L Linster; Eva Medina; Rudi Balling; Karsten Hiller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

Review 8.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Comparative in vivo gene expression of the closely related bacteria Photorhabdus temperata and Xenorhabdus koppenhoeferi upon infection of the same insect host, Rhizotrogus majalis.

Authors:  Ruisheng An; Srinand Sreevatsan; Parwinder S Grewal
Journal:  BMC Genomics       Date:  2009-09-15       Impact factor: 3.969

10.  Innovative approach for transcriptomic analysis of obligate intracellular pathogen: selective capture of transcribed sequences of Ehrlichia ruminantium.

Authors:  Loïc Emboulé; France Daigle; Damien F Meyer; Bernard Mari; Valérie Pinarello; Christian Sheikboudou; Virginie Magnone; Roger Frutos; Alain Viari; Pascal Barbry; Dominique Martinez; Thierry Lefrançois; Nathalie Vachiéry
Journal:  BMC Mol Biol       Date:  2009-12-24       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.